For example, a breast and ovarian cancer BM study by Reuten et al. (45) identified that NID2 was the third most strongly associated BM protein with poor survival in breast cancer, behind well-known cancer-associated matrix proteins laminin α5 (LAMA5) and fibronectin. This evidence concerns the gene NID2 and breast carcinoma.